| A Seamless Phase II/III, Observer-blind, to Evaluate Immunogenicity and Safety of Chikungunya Virus Vaccine in Healthy Subjects 12-65Years of Age. (NCT07555392) | Bharat Biotech International Limited | 2026-04-20 |
| Safety and Immunogenicity of a Mycobacterium Tuberculosis Vaccine MTBVAC in Healthy Indian Adults and Adolescents (BBV169/2024) (NCT06997367) | Bharat Biotech International Limited | 2025-03-27 |
| Tuberculosis Vaccine in Healthy Indian Adults (NCT06438978) | Bharat Biotech International Limited | 2024-01-19 |
| The Efficacy of Oral Rotavirus Vaccine 116E (ROTAVAC 5D) in Chilean Infants (NCT06200844) | Bharat Biotech International Limited | 2023-07-07 |
| To Evaluate Safety of Oral Cholera Vaccine Hillchol® (BBV131) (NCT05732766) | Bharat Biotech International Limited | 2023-02-04 |
| Phase III Study of BBV154 Intranasal Vaccine in Healthy Volunteers (NCT05522335) | Bharat Biotech International Limited | 2022-04-16 |
| Phase 3 Study to Evaluate Immunogenicity and Safety of BBV154 Booster Dose (NCT05567471) | Bharat Biotech International Limited | 2022-02-26 |
| A Phase III Randomized, Modified Double-blind, Multi-centric, Comparative Study, to Evaluate the Non-inferiority of Immunogenicity and Safety of Hillchol® (BBV131)to Shanchol™ Along With Lot-to-lot Consistency of Hillchol®(BBV131). (NCT05507229) | Bharat Biotech International Limited | 2022-02-22 |
| BBV152/BBV154 Heterologus Prime-Boost Study (NCT05639998) | Bharat Biotech International Limited | 2021-09-01 |
| COVAXIN in a Pediatric Cohort (NCT04918797) | Bharat Biotech International Limited | 2021-05-26 |
| Safety and Immunogenicity of an Intranasal SARS-CoV-2 Vaccine (BBV154) for COVID-19 (NCT04751682) | Bharat Biotech International Limited | 2021-03-01 |
| An Efficacy and Safety Clinical Trial of an Investigational COVID-19 Vaccine (BBV152) in Adult Volunteers (NCT04641481) | Bharat Biotech International Limited | 2020-11-16 |
| Whole-Virion Inactivated SARS-CoV-2 Vaccine (BBV152) for COVID-19 in Healthy Volunteers (NCT04471519) | Bharat Biotech International Limited | 2020-07-15 |
| Evaluate Immunogenicity, Safety, and Reactogenicity of Rotavac in Healthy Infants in Vietnam (NCT04596696) | Bharat Biotech International Limited | 2017-12-20 |